Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
Details for Australian Patent Application No. 2006239723 (hide)
International Classifications
Event Publications
1 November 2007 PCT application entered the National Phase
PCT publication WO2006/113959 Priority application(s): WO2006/113959
13 August 2009 Assignment before Grant
Sandoz AG; Boehringer Ingelheim Austria GmbH The application has been assigned to Sandoz AG; Boehringer Ingelheim RCV GmbH & Co KG
22 December 2011 Application Accepted
Published as AU-B-2006239723
19 April 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006239726-Animal models for cell therapy and cell based gene therapy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser